Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study of multiple
ascending iv doses of MEDI341 in male and female subjects with Parkinson's Disease.